Using ChIP-chip technology to reveal common principles of transcriptional repression in normal and cancer cells.
about
Role of MXD3 in proliferation of DAOY human medulloblastoma cellsZNF274 recruits the histone methyltransferase SETDB1 to the 3' ends of ZNF genesInsights from genomic profiling of transcription factorsHistone deacetylases mediate the silencing of miR-15a, miR-16, and miR-29b in chronic lymphocytic leukemiaCell-type selective chromatin remodeling defines the active subset of FOXA1-bound enhancersFormaldehyde crosslinking: a tool for the study of chromatin complexes.Global reorganization of replication domains during embryonic stem cell differentiationA method to quantify mouse coat-color proportions.Genome-wide analysis of aberrant methylation in human breast cancer cells using methyl-DNA immunoprecipitation combined with high-throughput sequencingGenome-wide views of chromatin structureTemporal ChIP-on-Chip of RNA-Polymerase-II to detect novel gene activation events during photoreceptor maturation.Global profiling of histone and DNA methylation reveals epigenetic-based regulation of gene expression during epithelial to mesenchymal transition in prostate cells.Inference of hierarchical regulatory network of estrogen-dependent breast cancer through ChIP-based data.Signatures of polycomb repression and reduced H3K4 trimethylation are associated with p15INK4b DNA methylation in AML.Genome-wide analysis reveals PADI4 cooperates with Elk-1 to activate c-Fos expression in breast cancer cells.Global loss of DNA methylation uncovers intronic enhancers in genes showing expression changes.E2F in vivo binding specificity: comparison of consensus versus nonconsensus binding sites.Temporal uncoupling of the DNA methylome and transcriptional repression during embryogenesisGenome-wide principles of gene regulation by the vitamin D receptor and its activating ligandDifferences among brain tumor stem cell types and fetal neural stem cells in focal regions of histone modifications and DNA methylation, broad regions of modifications, and bivalent promoters.Integrating the multiple dimensions of genomic and epigenomic landscapes of cancer.The SMARCA2/4 ATPase Domain Surpasses the Bromodomain as a Drug Target in SWI/SNF-Mutant Cancers: Insights from cDNA Rescue and PFI-3 Inhibitor Studies.Genome-wide methylation analysis of prostate tissues reveals global methylation patterns of prostate cancerHDAC Inhibition Induces MicroRNA-182, which Targets RAD51 and Impairs HR Repair to Sensitize Cells to Sapacitabine in Acute Myelogenous LeukemiaAxitinib blocks Wnt/β-catenin signaling and directs asymmetric cell division in cancerMapping key features of transcriptional regulatory circuitry in embryonic stem cells.Open chromatin in pluripotency and reprogrammingIntragenic DNA methylation: implications of this epigenetic mechanism for cancer research.The osteoblast to osteocyte transition: epigenetic changes and response to the vitamin D3 hormone.DNA methylation temporal profiling following peripheral versus central nervous system axotomy.Chemical Proteomics Identifies Druggable Vulnerabilities in a Genetically Defined Cancer.How low can you go? Pushing the limits of low-input ChIP-seq.PCAF-dependent epigenetic changes promote axonal regeneration in the central nervous system.
P2860
Q21090897-FD4CEF81-BE4F-4682-8189-153C54FC9A4CQ24318366-90FB3A60-58DF-4D73-8072-6E2C0608A0B1Q24611607-AB68F33F-1995-4BFA-8975-7BDFC99F771EQ24633394-8FAF152F-D1FD-4E26-9C7F-6F5D7CA52DC5Q24651915-04FB19F3-A381-4BB4-81E2-667430A6B024Q30278723-F880B2C1-166D-443E-8C6D-753342DA592CQ33374614-5CF0D800-DDBC-4CBA-8B93-8A830AB1D0ADQ33436730-3E05FE44-C01C-48F5-A804-A01CCD3A2426Q33534062-079FEA1B-78C0-44FD-8B89-CDB2664EE9A7Q33611702-DB7EC1AF-99F2-4C12-AAD6-E1C402752FCEQ33655857-3BB2968B-FF98-4A00-A73A-76E37C2A388DQ33756164-5AA1165F-FC02-41B5-BF43-C6BEA4D8E1E7Q33774643-C867C274-F807-4919-9F48-E5441B040C9EQ33805966-1602595B-F4E9-4897-ABC1-59E15C9004C0Q33926858-496F5291-4B9B-4949-A55B-AAB4F179963BQ34374752-A38ACDD9-AAE4-495E-BDAD-146356674C25Q34845654-CD720262-CF89-4A79-9889-927DF412B99BQ35145517-6DFF46C3-C4F4-450C-840E-C07AD446F4B5Q35230672-15F9524A-937E-4CB9-BF2D-5CD96C7DF9D9Q35233181-E92F7B1A-7F96-4FAC-AD33-11C9A48C59BDQ36152246-5975306D-6D70-47CE-BA3D-E02BE74B2508Q36584337-8C6356BE-A7D6-4952-B394-832BE884781CQ36888332-B5D7A32E-4F2C-42AA-B8B5-417A1F433AF2Q37100102-A8BA86B7-DB87-42FA-AB16-B5C97C018C61Q37200030-93221C38-21B6-4BE1-A3A6-03216C2DFF8AQ37331003-98BD8AF3-CF16-463E-84BF-F217B72B3A6BQ37477736-DD586EBB-E4E4-43EC-A2BB-3886B272AC10Q37968137-5D82431A-5D20-4851-974A-D500063A0B85Q38990147-3CAB5750-357E-43C7-A1A3-71DEE06A186EQ39985096-2325E6A1-5872-4857-BF3D-3AF7EDCC3154Q47153468-0843C11A-FF75-41FE-B9BB-FEEDB035F1F9Q47583391-3106BE20-A813-41D0-A269-55F0D3DDA909Q54363458-D5C663C4-4ABD-438E-AB8F-66BE941EAA82
P2860
Using ChIP-chip technology to reveal common principles of transcriptional repression in normal and cancer cells.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Using ChIP-chip technology to ...... on in normal and cancer cells.
@ast
Using ChIP-chip technology to ...... on in normal and cancer cells.
@en
type
label
Using ChIP-chip technology to ...... on in normal and cancer cells.
@ast
Using ChIP-chip technology to ...... on in normal and cancer cells.
@en
prefLabel
Using ChIP-chip technology to ...... on in normal and cancer cells.
@ast
Using ChIP-chip technology to ...... on in normal and cancer cells.
@en
P2093
P2860
P356
P1433
P1476
Using ChIP-chip technology to ...... on in normal and cancer cells.
@en
P2093
Alina Rabinovich
Henriette O'Geen
Luis G Acevedo
Roland Green
Sharon L Squazzo
Sushma S Iyengar
Vitalina M Komashko
P2860
P304
P356
10.1101/GR.074609.107
P577
2008-03-17T00:00:00Z